BioNTech, the German pharmaceutical company known for its collaboration with Pfizer on the development of a Covid-19 vaccine, has surpassed market expectations with its third-quarter earnings. Despite analysts anticipating a loss, BioNTech reported earnings per share of 0.67 euros (72 cents). While the figures were lower compared to the previous year, the company's revenue also … [Read more...] about BioNTech Surprises with Strong Earnings in Q3
Footer
